Vanguard Global Advisers
CORZ icon

Vanguard Global Advisers’s Core Scientific CORZ Stock Holding History

Vanguard Global Advisers’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Sell
123,358
-2,775
-2% -$65.3K ﹤0.01% 982
2026
Q1 		$1.89M Buy
+126,133
New +$2.15M ﹤0.01% 1234

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Global Advisers's CORZ Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Core Scientific (CORZ) stake by 2.2% in Q2 2026, selling an estimated $65.3K and leaving 123,358 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #982.

Vanguard Global Advisers first reported a position in CORZ in Q1 2026 and has held it in 2 quarters since. 405 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Vanguard Global Advisers held 123,358 shares of Core Scientific worth $3.16M as of Q2 2026.
  • Vanguard Global Advisers sold 2,775 Core Scientific shares in Q2 2026, an estimated $65.3K.
  • Core Scientific made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #982 holding.
  • Vanguard Global Advisers first reported a position in Core Scientific in Q1 2026 and has held it in 2 quarters since.
  • 405 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.